Silver Book Fact

Healthcare costs of atrial fibrillation

Atrial fibrillation (AF) is a major economic burden for society with the biggest cost driver being hospitalizations—accounting for 52% of costs. Drugs for AF account for 23% of costs, consultations at 9%, further investigations at 8%, loss of work at 6%, and paramedical procedures at 2%.

Le Heuzey, J-Y, O Paziaud, O Piot, SM Ait, X Copie, T Lavergne, and L Guize. Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study. Am Heart J. 2004; 147(1): 121-6. http://www.ahjonline.com/article/S0002-8703%2803%2900524-6/abstract

Reference

Title
Cost of Care Distribution in Atrial Fibrillation Patients: The COCAF study
Publication
Am Heart J
Publication Date
2004
Authors
Le Heuzey, J-Y, O Paziaud, O Piot, SM Ait, X Copie, T Lavergne, and L Guize
Volume & Issue
Volume 147, Issue 1
Pages
121-6
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • AFib prevalence projected to double by 2050
    By 2050, the prevalence of atrial fibrillation will have more than doubled since 2001—growing to an estimated 5.6 million to 12.1 million Americans.  
  • Atrial fibrillation as a contributory cause of death, 2011
    Atrial fibrillation is a contributory cause of death for around 93,000 Americans each year.  
  • Annual cost of AFib-related stroke in Medicare patients
    The annual cost of stroke in Medicare patients with atrial fibrillation is estimated at $8 billion.  
  • AFib prevalence, 2006
    As much as 1% of the U.S. population is estimated to have atrial fibrillation  
  • Total medical costs for Afib patients over 15-month period
    A study of Medicare beneficiaries with atrial fibrillation found that total medical costs for treating these patients during a 15-month follow-up period were an average of $24,000 per patient—63% of…